Definitive Healthcare announces timing of its fourth quarter and full year 2021 financial results conference call and webcast
Definitive Healthcare announces its fourth quarter and full year financial results will be released on February 23, 2022 after market close.
Definitive Healthcare launches Latitude Discovery for pre-commercial biopharma and medical device companies
Definitive Healthcare announces the availability of Latitude Discovery, a new product aimed at pre-commercial biopharma & medical device companies.
Definitive Healthcare set to join Russell 1000® Index
Definitive Healthcare (Nasdaq: DH) is set to join the Russell 1000® Index effective after the U.S. stock market opens on December 20, 2021.
Chief Product Officer Kate Shamsuddin Jensen recognized by Boston Business Journal and 2021 Stevie Awards for Women in Business
Definitive Healthcare’s Chief Product Officer Kate Shamsuddin Jensen recognized by Boston Business Journal and Stevie Awards for Women in Business.
Definitive Healthcare named a 2021 Top Place to Work by The Boston Globe for the fifth consecutive year
Definitive Healthcare has been named a Top Place to Work in Massachusetts in the category of large companies by The Boston Globe.
Definitive Healthcare to present at the Barclays Virtual Global Technology, Media and Telecommunications Conference
Definitive Healthcare CEO Jason Krantz and CFO Rick Booth will present at the Barclays Virtual Global Technology, Media and Telecommunications…
Definitive Healthcare announces closing of follow-on offering of 11,000,000 shares of Class A common stock
Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH) today announced the closing of its previously announced underwritten public…
Definitive Healthcare announces pricing of follow-on offering of 11,000,000 shares of Class A common stock
Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH) today announced the pricing of an underwritten public offering of 11,000,000 shares…
Definitive Healthcare announces launch of proposed follow-on offering of 11,000,000 shares of Class A common stock
Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH) today announced the commencement of an underwritten public offering of 11,000,000…